Bernard Canaud

Prof. Dr. Bernard Canaud

School of Medicine, Montpellier University, Montpellier, France
orcid

Research Focus & Metrics

Academic Career Length

45Years (1982-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 June 2006 in Kidney International
Verified
Journal Article
Closed access
BCBernard Canaud
Bernard Canaud
JBJ.L. Bragg-Gresham
J.L. Bragg-Gresham
MMM.R. Marshall
M.R. Marshall
SDS. Desmeules
S. Desmeules
BGB.W. Gillespie
B.W. Gillespie
FPF.K. Port
F.K. Port

1 July 2011 in Clinical Journal of the American Society of Nephrology
Verified
Journal Article
Open access
PDF file
BCBernard Canaud
Bernard Canaud
LTLin Tong
Lin Tong
FTFrancesca Tentori
Francesca Tentori
TATakashi Akiba
Takashi Akiba
AKAngelo Karaboyas
Angelo Karaboyas
FPFriedrich K. Port
Friedrich K. Port
Demand for hemodialysis among elderly patients is increasing worldwide. Although clinical care of this high-risk group is complex and challenging, no guidelines exist to inform hemodialysis practices. The Dialysis Outcomes and Practice Patterns Study (DOPPS) provides a unique opportunity to assess dialysis practices and associated outcomes among elderly versus younger patients on chronic in-center hemodialysis in 12 countries. Clinical characteristics, dialysis practices, and outcomes of elderly versus younger patients were compared among participants in four DOPPS regions in 2005 through 2007. Although participant mean age increased over time in all DOPPS countries, the percentage of elderly varied widely. Overall, comorbidities and malnutrition were more common in the elderly. Fistulae were used less frequently among elderly versus younger patients in Europe and North America but not in Australia, New Zealand, and Japan. No difference in treatment time was observed between elderly and younger patients after normalizing for body weight. In all regions, ultrafiltration rates were lower among elderly patients. Elderly patients reported poorer quality of life with respect to the physical but not mental component scores. Mortality risk was three- to sixfold higher in the elderly group, whereas causes of death overall were similar for elderly and younger patients. Elderly patients represent a different proportion of DOPPS participants across countries, possibly reflecting differences in policies and clinical practices. In general, hemodialysis practices in the elderly reflected each region's clinical patterns, with some variation by age group depending upon the practice.

1 December 2019 in Brazilian Journal of Nephrology
Verified
Journal Article
Open access
PDF file
BCBernard Canaud
Bernard Canaud
CCCharles Chazot
Charles Chazot
JKJeroen Koomans
Jeroen Koomans
ACAllan Collins
Allan Collins
Fluid volume and hemodynamic management in hemodialysis patients is an essential component of dialysis adequacy. Restoring salt and water homeostasis in hemodialysis patients has been a permanent quest by nephrologists summarized by the ‘dry weight’ probing approach. Although this clinical approach has been associated with benefits on cardiovascular outcome, it is now challenged by recent studies showing that intensity or aggressiveness to remove fluid during intermittent dialysis is associated with cardiovascular stress and potential organ damage. A more precise approach is required to improve cardiovascular outcome in this high-risk population. Fluid status assessment and monitoring rely on four components: clinical assessment, non-invasive instrumental tools (e.g., US, bioimpedance, blood volume monitoring), cardiac biomarkers (e.g. natriuretic peptides), and algorithm and sodium modeling to estimate mass transfer. Optimal management of fluid and sodium imbalance in dialysis patients consist in adjusting salt and fluid removal by dialysis (ultrafiltration, dialysate sodium) and by restricting salt intake and fluid gain between dialysis sessions. Modern technology using biosensors and feedback control tools embarked on dialysis machine, with sophisticated analytics will provide direct handling of sodium and water in a more precise and personalized way. It is envisaged in the near future that these tools will support physician decision making with high potential of improving cardiovascular outcome.

1 November 2015 in Kidney International
Verified
Journal Article
Open access
BCBernard Canaud
Bernard Canaud
CBCarlo Barbieri
Carlo Barbieri
DMDaniele Marcelli
Daniele Marcelli
FBFrancesco Bellocchio
Francesco Bellocchio
SBSudhir Bowry
Sudhir Bowry
EGEmanuele Gatti
Emanuele Gatti
Online hemodiafiltration (OL-HDF), the most efficient renal replacement therapy, enables enhanced removal of small and large uremic toxins by combining diffusive and convective solute transport. Randomized controlled trials on prevalent chronic kidney disease (CKD) patients showed improved patient survival with high-volume OL-HDF, underlining the effect of convection volume (CV). This retrospective international study was conducted in a large cohort of incident CKD patients to determine the CV threshold and range associated with survival advantage. Data were extracted from a cohort of adult CKD patients treated by post-dilution OL-HDF over a 101-month period. In total, 2293 patients with a minimum of 2 years of follow-up were analyzed using advanced statistical tools, including cubic spline analyses for determination of the CV range over which a survival increase was observed. The relative survival rate of OL-HDF patients, adjusted for age, gender, comorbidities, vascular access, albumin, C-reactive protein, and dialysis dose, was found to increase at about 55 l/week of CV and to stay increased up to about 75 l/week. Similar analysis of pre-dialysis β2-microglobin (marker of middle-molecule uremic toxins) concentrations found a nearly linear decrease in marker concentration as CV increased from 40 to 75 l/week. Analysis of log C-reactive protein levels showed a decrease over the same CV range. Thus, a convection dose target based on convection volume should be considered and needs to be confirmed by prospective trials as a new determinant of dialysis adequacy.

19 February 2004 in Nephrology Dialysis Transplantation
Verified
Journal Article
Open access
PDF file
SDSimon Desmeules
Simon Desmeules
RLRenée Lévesque
Renée Lévesque
IJIsabelle Jaussent
Isabelle Jaussent
HLHélène Leray-Moragues
Hélène Leray-Moragues
LCLofti Chalabi
Lofti Chalabi
BCBernard Canaud
Bernard Canaud
Background. No single measurement adequately defines protein-energy malnutrition. In the dialysis population, somatic protein mass, a useful marker of protein malnutrition, is estimated using the creatinine index (CI), lean body mass (LBM) or both, but the clinical usefulness of these indices remains uncertain. Moreover, calculating these indices requires formal creatinine kinetics or urine and dialysate collection. A simpler method to estimate the creatinine generation rate (GCr) probably might widen its use. Methods. We evaluated the usefulness of creatinine-based indices for predicting mortality in a cohort of 226 French haemodiafiltration patients using the Cox proportional hazards method. We also proposed simple yet precise formulas to calculate post-dialysis creatinine (Crpost) concentrations and derive creatinine generation rates (GCr) from readily available measures. These formulas were developed using a large database containing more than 10 000 measured Crpost and GCr values based on formal creatinine modelling. A single set of monthly values was used to evaluate the validity of the formulas. Results. When adjusted for comorbidities, sex and Kt/V, CI and LBM/body weight (LBM/BW) were better predictors of 5 year all-cause mortality than urea-based indices [survival relative risk (RR) = 0.24, P<0.01 for CI<22 mg/kg/day; RR = 0.33, P<0.02 for LBM/BW<0.75]. When the cohort was divided according to gender, similar results were found in males, but not in females. The different formulas allowed adequate prediction of Crpost and GCr and classification of patients with good accuracy (CI<22: sensitivity = 94%, specificity = 82%; LBW/BW<0.75: sensitivity = 89%, specificity = 90%). Conclusions. In a haemodiafiltration population, CI and LBM are excellent predictors of long-term survival. In anuric Caucasian haemodialysis patients, CI and LBM can be estimated from biochemical and anthropometric measurements without relying on formal modelling.

1 November 2020 in Kidney International Reports
Verified
Journal Article
Open access
BCBernard Canaud
Bernard Canaud
JKJeroen P. Kooman
Jeroen P. Kooman
NSNicholas M. Selby
Nicholas M. Selby
MTMaarten W. Taal
Maarten W. Taal
SFSusan Francis
Susan Francis
PKPeter Kotanko
Peter Kotanko
Hemodialysis has saved many lives, albeit with significant residual mortality. Although poor outcomes may reflect advanced age and comorbid conditions, hemodialysis per se may harm patients, contributing to morbidity and perhaps mortality. Systemic circulatory “stress” resulting from hemodialysis treatment schedule may act as a disease modifier, resulting in a multiorgan injury superimposed on preexistent comorbidities. New functional intradialytic imaging (i.e., echocardiography, cardiac magnetic resonance imaging [MRI]) and kinetic of specific cardiac biomarkers (i.e., Troponin I) have clearly documented this additional source of end-organ damage. In this context, several factors resulting from patient-hemodialysis interaction and/or patient management have been identified. Intradialytic hypovolemia, hypotensive episodes, hypoxemia, solutes, and electrolyte fluxes as well as cardiac arrhythmias are among the contributing factors to systemic circulatory stress that are induced by hemodialysis. Additionally, these factors contribute to patients’ symptom burden, impair cognitive function, and finally have a negative impact on patients’ perception and quality of life. In this review, we summarize the adverse systemic effects of current intermittent hemodialysis therapy, their pathophysiologic consequences, review the evidence for interventions that are cardioprotective, and explore new approaches that may further reduce the systemic burden of hemodialysis. These include improved biocompatible materials, smart dialysis machines that automatically may control the fluxes of solutes and electrolytes, volume and hemodynamic control, health trackers, and potentially disruptive technologies facilitating a more personalized medicine approach.